Altogether, we review synaptic activity modulation of the BDNF/TrkB/PKC signaling to sustain NMJ function, its and other kinases’ disturbances in ALS and physical and molecular mechanisms to delay disease progression. This evidence concerns the gene NTRK2 and amyotrophic lateral sclerosis.